Patent details

Basic Information

Publication number:

EP2294083

PCT Application Number:

PCT/GB/2009/001026

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP097354989

PCT Publication Number:

WO/2009/130459

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EPITOPES OF IL-17A AND IL-17F AND ANTIBODIES SPECIFIC THERETO

French Title of Invention:

ÉPITOPES D IL-17A ET D IL-17F, ET ANTICORPS SPÉCIFIQUES À CEUX-CI

German Title of Invention:

EPITOPE VON IL-17A UND IL-17F UND DAFÜR SPEZIFISCHE ANTIKÖRPER

SPC Number:

Dates

Filing date:

22/04/2009

Grant date:

29/07/2015

EP Publication Date:

29/07/2015

PCT Publication Date:

29/10/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/03/2011

EP B1 Publication Date:

29/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

22/04/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/04/2009

 

 

Name:

UCB Biopharma SPRL

Address:

Allée de la Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:

SHI Jijye

Address:

United Kingdom (GB)

2

Name:

HENRY Alistair, James

Address:

United Kingdom (GB)

3

Name:

CESKA Thomas, Allen

Address:

United Kingdom (GB)

Priority

Priority Number:

0807413

Priority Date:

23/04/2008

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07K 14/54;

Annual Fees

Annual Fee Due Date:

30/04/2026

Annual Fee Number:

18

Annual Fee Amount:

262 Euro

Expected Payer:

Last Annual Fee Payment Date:

16/04/2025

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages